CVS Health said four new members will be added to its board from the hedge fund Glenview Capital, which had been pushing for changes at the diversified healthcare giant.

CVS Health has added four new board members, including the chief executive of a hedge fund that has been critical of the struggling healthcare giant.

CVS Health said on Monday it added four new members to its board including hedge fund Glenview Capital's chief executive Larry Robbins as part of a standstill agreement with the activist investor. Shares of CVS rose 2% to $54.